PHAR News and Press, Pharming Group N.V. From 04/26/22

Pharming Group (NASDAQ:PHAR) said the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) granted promising innovative medicine (PIM) designation to leniolisib to treat activated phosphoinositide 3-kinase delta syndrome (APDS), a rare immunodeficiency disease. The comp...

Pharming receives agreement of Paediatric Investigation Plan and Promising Innovative Medicine designation for leniolisib from UK MHRA PR Newswire An agreed Paediatric Investigation Plan (PIP) is the regulatory pathway to market authorization for leniolisib as a trea...

Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting Canada NewsWire LEIDEN, Netherlands , April 1, 2022 /CNW/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amste...

Pharming Group N.V. (PHGUF) Full Year 2021 Earnings Conference Call March 17, 2022 9:00 AM ET Company Participants Sijmen Vries - Executive Director and Chief Executive Officer Jeroen Wakkerman - Chief Financial Officer Anurag Relan - Chief Medical Officer Conference Call Participants Hartaj ...

Gainers: Palisade Bio (NASDAQ:PALI) +23%. Pharming Group (NASDAQ:PHAR) +14%. Entasis Therapeutics (NASDAQ:ETTX) +13%. Epizyme (NASDAQ:EPZM) +11%. IceCure Medical (NASDAQ:ICCM) +10%. Losers: LogicBio Therapeutics (NASDAQ:LOGC) -50%. Pardes Bios...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re beginning another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! Source: ventdusud / Shutterstock.com News moving stocks this morning inclu...

Pharming Group N.V. (PHGUF) Q3 2021 Results Conference Call October 28, 2021 07:30 AM ET Company Participants Sijmen de Vries - CEO Dr. Anurag Relan - Chief Medical Officer Jeroen Wakkerman - CFO Conference Call Participants Hartaj Singh - Oppenheimer & Co. Joe Pantginis - H.C. Wainright ...

Pharming Group N.V. (PHGUF) Q2 2021 Earnings Conference Call August 05, 2021 01:00 PM ET Company Participants Sijmen De Vries - Chief Executive Officer Jeroen Wakkerman - Chief Financial Officer Conference Call Participants Joe Pantginis - Wainwright Alex Cogut - Kempen Christian Glennie - St...

naphtalina/iStock via Getty Images A few collaboration deals in the drug-development space are sparking big gains in Thursday's pre-market action. Spero Therapeutics (SPRO) posted a notable advance, thanks to an investment from drug-making giant Pfizer (PFE). Orchard Therapeutics (ORTX) climb...

Orchard Therapeutics (ORTX) and Pharming Group (PHAR) announce a strategic collaboration to research, develop, manufacture and commercialize OTL-105, an investigational ex vivo autologous hematopoietic stem cell ((HSC)) gene therapy for the treatment of hereditary angioedema ((HAE)), a rare d...